Somatostatin-14 mainly binds the somatostatin receptor subtype 2 in human neuroblastoma tumors

Neuroendocrinology

Volumn 63, Issue 2, 1996, Pages 188-197

  Prévost, Grégoire ^a   Veber, Nathalie ^a   Viollet, Cécile ^b   Roubert, Véronique ^c   Roubert, Pierre ^c   Bénard, Jean ^d   Eden, Peter ^e  

^a Institut d'Oncologie Cellulaire et Moleculaire Humaine   (France)

^b INSERM   (France)

^c Institut Henri Beaufour   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Biomeasure Inc   (United States)

Author keywords

Clinical neuroendocrinology; Neuroblastoma; Receptor; Somatostatin receptor

Indexed keywords

IODINE 125; MEMBRANE PROTEIN; RECEPTOR SUBTYPE; SOMATOSTATIN 14; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ARTICLE; BRAIN CORTEX; GANGLIONEUROMA; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BASE SEQUENCE; BLOTTING, NORTHERN; BRAIN NEOPLASMS; CLONING, MOLECULAR; CROSS-LINKING REAGENTS; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEUROBLASTOMA; PEPTIDES, CYCLIC; POLYMERASE CHAIN REACTION; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TUMOR CELLS, CULTURED;

EID: 0030052470     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000126957     Document Type: Article

References (41)

1. Crist WM, Kun LE: Common solid tumors of childhood, N Engl J Med 1991:324:461-471.
2. Sccgcr RC, Brodeur GM, Sather H, Dalton A, Siegel S, Wong K, Hammon D: Association of multiple copies of the N-m.tr oncogene with rapid progression of neuroblastoma, N Engl J Med 1985;313:1111-1117.
3. Viollct C, Prévost G, Maubert E, Faivre-Bau-man A, Gardctte R, Kordon C, Loudcs C, Sla-rna A, Epelbaum J: Molecular pharmacology of somatostatin receptors, Fundam Clin Pharmacol 1995;9:107-113.
4. Epelbaum J, Bertherat J, Prévost G, Kordon C, Meyerhof W, Wulfsen I, Richter D, Plouin PF: Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal extraadrenal, and malignant pheochromo-cvtomas, J Clin Endocrinol Mctab 1995;80: 1837-1844.
5. Prévost G, Bourgeois Y, Mormont C, Lerrant Y, Véber N, Poupon MF, Thomas F: Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma, Life Sci 1994;55:155-162.
6. Taylor JE, Bogden A, Moreau JP, Coy DH: In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue, Biochem Biophys Res Commun 1988;153:81-86.
7. Maggi M, Baldi E, Finctti G, Franccschelli F, Brocchi A, Lanzillotti R, Scrio M, Cambni M, Thiele J: Identification, characterization and biological activity of somatostatin receptors in human neuroblastoma cell lines, Cancer Res 1994;54:124-133.
8. Reubi JC, Schaer JC, Waser B, Mengod G: Expression and localization of somatostatin receptor sstl, sst2 and sst3 messenger RNAs in primary human tumors using in situ hybridization, Cancer Res 1994;54:3455-3459.
9. O'Dorisio MS, Chen F, O'Dorisio M, Wrav D, Qualman SJ: Characterization of somatostatin receptors on human neuroblastoma tumors, Cell Growth Differ 1994;5:1-8.
10. Jonas S, John M, Boese-Landgraf J, Haring R, Prévost G, Thomas F, Rosewisz S, Riecken EO, Wicdcnmann B, Neuhaus P: Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues, Langenbecks Arch Chir 1995:380:90-95.
11. Brazcau P, Vale W, Burgas R, Ling N, Butscher M, Rivier J, Guillemin R: Hypothalamic polypeptides that inhibit the secretion of immuno-reactive pituitary growth hormone, Science 1973:179:77-79.
12. Lamberts SW, Krening E, Reubi JC: The role of somatostatin and its analogs in the diagnosis and the treatments of tumors, Endocr Rev 1991;12:450-481.
13. Krenning EP, Breeman WAP, Kooij PP, Lameris JS, Bakkcr WH, Kopper JW, Ausema L, Reubi JC, Lamberts SWJ: Localization of en-docrine-rclalcd tumors with radioiodinated analogue of somatostatin, Lancet 1991:8632: 242-244.
14. Murthy KK, Srikant CB, Patel YC: Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: Affinity cross-linking and molecular characterization, Endocrinology 1990;125:948-956.
15. Prévost G, Foehrlé E, Thomas F, Pihan I, Veber N, Starzcc A, Israel L: Growth of human breast cancer cells inhibited by the somatostatin analogue B1M23014 (somatuline), Endocrinology 1991;128:323-330.
16. Prévost G, Lanson M, Thomas F, Veber N, Gonzalez W, Bcaupain R, Starzec A, Bogden AE: Molecular heterogeneity of somatostatin analogue BIM23014C receptors in human breast carcinoma using cross-linking assay, Cancer Res 1992;52:843-850.
17. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S: Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney, Proc Natl Acad Sci USA 1992;89:251-255.
18. Yasuda Y, Rens-Domanio S, Breeder CD, Law S, Saper CB, Rcisine T, Bell GI: Cloning of novel somatostatin receptor sstR3 coupled to adenylvl cyclase, J Biol Chcm 1992.267: 20422-20428.
19. Bruno JF, Xu Y, Song J, Berelowitz M: Molecular cloning and functional expression of a brain-specific somatostatin receptor, Proc Natl Acad Sci USA 1992:89:11151-11155.
20. O'Carroll AM, Lolait S, Konig M, Mahan LC: Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28, Mol Pharmacol I992.42: 939-946.
21. Roher L, Raulf F, Bruns C, Buettncr R, Hof-staedter F, Schule R: Cloning and characterization of a fourth human somatostatin receptor, Proc Natl Acad Sci USA 1993:90:4196-4200.
22. Vanetti M, Kouba M, Wang X, Vogt G, Hollt V: Cloning and expression of a novel mouse somatostatin receptor (sst2B), FEBS Lett 1992; 311:290-294.
23. Taylor JE, Theveniau MA, Bashirzadeh R, Rcisine T, Eden P: Detection of somatostatin receptor subtype 2 (sst2) in established tumors and tumor cell lines; Evidence for sst2 heterogeneity, Peptides 1994;7:1229-1236.
24. Raynor K, Murphy WA, Coy DH, Taylor JE, Moreau JP, Yasuda K, Bell GI, Reisine T: Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides, Mol Pharmacol 1993;43:838-843.
25. Raynor K, O'Carroll AM, Kong H, Yasuda K, Mahan LC, Bell GI, Reisine T: Characterization of cloned somatostatin receptors sstR4 and sstR5, Mol Pharmacol 1993:44:385-392.
26. Yamada Y, Reisine T, Law S, lhara Y, Kubota A, Kagimoto S, Scino M, Seino Y, Bell G, Scino S: Somatostatin receptors, and expanding gene family: Cloning and functional characterization of human sstR3, a protein coupled to ade-nylyl cyclase, Mol Endocrinol 1992:12:2136-2142.
27. Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Sorneya Y, Ihara Y, Li Q, Imura H, Seino S, Seino Y: Cloning, functional expression and pharmacological characterization of a fourth and a fifth human somatostatin receptor subtype, BBRC 1993:195:844-852.
28. O’Carroll AM, Raynor K, Lolait S, Reisine T: Characterization of cloned human somatostatin receptor sstR5, Mol Pharmacol 1994:46: 291-298.
29. Patel YC, Srikant CB: Subtype selectivity of peptide analogs for all five cloned human SRIH receptors (hsstrl-5), Endocrinology 1994:135: 2814-2817.
30. Eden P, Taylor JE: Somatostatin receptor sub-type gene expression in human and rodent tumors, Life Sci 1993:53:85-90.
31. Ferrandis E, Da Silva J, Riou G, Bénard J: Coactivation of the MDR1 and MYCN genes in human ncuroblasts during the metastatic process in the nude mouse, Cancer Res 1994; 54:2256-2261.
32. Biedler J, Hclson L, Spenlcr B: Morphology and growth tumorigenicily and cytogenetics of human neuroblastoma cells in continuous culture, Cancer Res 1973:33:2643-2652.
33. Bettan-Rcnaud L, Baylc C, Teyssier JR, Bénard J: Stability of phenotypic and genotypic traits during the establishment of a human neuroblastoma cell line: IGR-N-835, Int J Cancer 1989:44:460-464.
34. Chomczvnsky P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocya-nate phenol chloroform extraction, Anal Bio-chem 1987;162:156-159.
35. Spanakis E: Problems related to the interpretation of autoradiographic data gene expression using common constitutive transcripts as controls, Nucleic Acids Res 1993;21:3809-3819.
36. Buscail L, Delesque N, Estevc JP, Saint-Laurent N, Prats H, Clerc P, Robberech P, Bell GI, Liebow C, Schally AV, Vaysse N, Susini C: Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes sstRl and sstR2, Proc Natl AcadSci USA 1994:91:2315-2319.
37. Hershberger RE, Newman BL, Florio T, Bun-zow J, Civclli O, Li XJ, Forte M, Stork P: The somatostatin receptors sstRl and sstR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin-sensitive pathways, Endocrinology 1994:134: 1277-1285.
38. Patel YC, Panetta R, Escher E, Greenwood M, Srikant CB: Expression of multiple somatostatin receptor genes in AT-20 cells, J Biol Chem 1994;269:1506-1509.
39. Taylor JE, Thcveniau MA, Bashirzadeh B, Rcisine T, Eden P: Detection of somatostatin receptor subtype 2 in established tumors and tumor cell lines: Evidence for sstR2 heterogeneity, Peptides 1994:7:1229-1236.
40. Prévost G, Provost Ph, Lanson M, Salle V, Thomas F: A cross-linking assay allows the detection of receptors in the somatostatin analogue lanreotide in human breast tumours, Eur J Cancer 1993:29:1589-1592.
41. Bogden AE, Taylor JE, Moreau JP, Coy DH: Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration, Cancer Res 1990:50:2646-2650.